These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 24992553

  • 1. Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis.
    Skoner DP, LaForce CF, Nathan RA, Urdaneta ER, Zielinski MA, Sacavage SD, Franklin KB, Wu MM.
    Allergy Asthma Proc; 2014; 35(4):338-45. PubMed ID: 24992553
    [Abstract] [Full Text] [Related]

  • 2. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
    Day JH, Briscoe MP, Rafeiro E, Hewlett D, Chapman D, Kramer B.
    Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
    [Abstract] [Full Text] [Related]

  • 3. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
    Fantin S, Maspero J, Bisbal C, Agache I, Donado E, Borja J, Mola O, Izquierdo I, international Rupatadine study group.
    Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.
    Sastre J, Mullol J, Valero A, Valiente R, Bilastine Study Group.
    Curr Med Res Opin; 2012 Jan; 28(1):121-30. PubMed ID: 22077106
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment.
    Murray JJ, Nathan RA, Bronsky EA, Olufade AO, Chapman D, Kramer B.
    Allergy Asthma Proc; 2002 Jan; 23(6):391-8. PubMed ID: 12528605
    [Abstract] [Full Text] [Related]

  • 6. Nasal nitric oxide and nasal eosinophils decrease with levocetirizine in subjects with perennial allergic rhinitis.
    Bautista AP, Eisenlohr CP, Lanz MJ.
    Am J Rhinol Allergy; 2011 Jan; 25(6):383-7. PubMed ID: 22185740
    [Abstract] [Full Text] [Related]

  • 7. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
    Lai DS, Lue KH, Hsieh JC, Lin KL, Lee HS.
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
    [Abstract] [Full Text] [Related]

  • 8. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A.
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 10. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH, Briscoe M, Widlitz MD.
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
    Day JH, Briscoe MP, Rafeiro E, Ratz JD, Ellis AK, Frankish CW, Chapman D, deGuia EC, Kramer B, Warner C.
    Allergy Asthma Proc; 2005 May; 26(4):275-82. PubMed ID: 16270720
    [Abstract] [Full Text] [Related]

  • 12. The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial.
    Noonan MJ, Raphael GD, Nayak A, Greos L, Olufade AO, Leidy NK, Champan D, Kramer B.
    Clin Exp Allergy; 2003 Mar; 33(3):351-8. PubMed ID: 12614450
    [Abstract] [Full Text] [Related]

  • 13. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire.
    Bousquet J, Duchateau J, Pignat JC, Fayol C, Marquis P, Mariz S, Ware JE, Valentin B, Burtin B.
    J Allergy Clin Immunol; 1996 Aug; 98(2):309-16. PubMed ID: 8757208
    [Abstract] [Full Text] [Related]

  • 14. Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis.
    Nayak AS, Berger WE, LaForce CF, Urdaneta ER, Patel MK, Franklin KB, Wu MM.
    Allergy Asthma Proc; 2017 May 01; 38(3):222-230. PubMed ID: 28441993
    [Abstract] [Full Text] [Related]

  • 15. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO.
    Ann Allergy Asthma Immunol; 2006 Sep 01; 97(3):375-81. PubMed ID: 17042145
    [Abstract] [Full Text] [Related]

  • 16. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
    Murris-Espin M, Melac M, Charpentier JC, Didier A.
    Ann Allergy Asthma Immunol; 1998 May 01; 80(5):399-403. PubMed ID: 9609610
    [Abstract] [Full Text] [Related]

  • 17. Further improvement of quality of life by cetirizine in perennial allergic rhinitis as a function of treatment duration.
    Burtin B, Duchateau J, Pignat JC, Donnelly F, Bousquet J.
    J Investig Allergol Clin Immunol; 2000 May 01; 10(2):66-70. PubMed ID: 10879992
    [Abstract] [Full Text] [Related]

  • 18. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
    Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, Grossman J.
    Ann Allergy Asthma Immunol; 1996 May 01; 76(5):448-54. PubMed ID: 8630719
    [Abstract] [Full Text] [Related]

  • 19. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis.
    Kim MK, Lee SY, Park HS, Yoon HJ, Kim SH, Cho YJ, Yoo KH, Lee SK, Kim HK, Park JW, Park HW, Chung JH, Choi BW, Lee BJ, Chang YS, Jo EJ, Lee SY, Cho YS, Jee YK, Lee JM, Jung J, Park CS.
    Clin Ther; 2018 Jul 01; 40(7):1096-1107.e1. PubMed ID: 29945738
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial.
    Potter PC, Paediatric Levocetirizine Study Group.
    Ann Allergy Asthma Immunol; 2005 Aug 01; 95(2):175-80. PubMed ID: 16136768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.